These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 8275973)

  • 1. Essential role of endogenous estrogen in directly stimulating mammary growth demonstrated by implants containing pure antiestrogens.
    Silberstein GB; Van Horn K; Shyamala G; Daniel CW
    Endocrinology; 1994 Jan; 134(1):84-90. PubMed ID: 8275973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct action of 17 beta-estradiol on mouse mammary ducts analyzed by sustained release implants and steroid autoradiography.
    Daniel CW; Silberstein GB; Strickland P
    Cancer Res; 1987 Nov; 47(22):6052-7. PubMed ID: 3664507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local versus systemically mediated effects of estrogen on normal mammary epithelial cell deoxyribonucleic acid synthesis.
    Haslam SZ
    Endocrinology; 1988 Mar; 122(3):860-7. PubMed ID: 3342755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific transcriptional response of four blockers of estrogen receptors on estradiol-modulated genes in the mouse mammary gland.
    Calvo E; Luu-The V; Belleau P; Martel C; Labrie F
    Breast Cancer Res Treat; 2012 Jul; 134(2):625-47. PubMed ID: 22678160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of mouse mammary ductal growth regulation using slow-release plastic implants.
    Silberstein GB; Daniel CW
    J Dairy Sci; 1987 Sep; 70(9):1981-90. PubMed ID: 3668054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of mammary gland development in estrogen receptor-alpha knockout mice.
    Bocchinfuso WP; Lindzey JK; Hewitt SC; Clark JA; Myers PH; Cooper R; Korach KS
    Endocrinology; 2000 Aug; 141(8):2982-94. PubMed ID: 10919287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ductal morphogenesis in the mouse mammary gland: evidence supporting a role for epidermal growth factor.
    Coleman S; Silberstein GB; Daniel CW
    Dev Biol; 1988 Jun; 127(2):304-15. PubMed ID: 3259938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tamoxifen inhibition of prolactin action in the mouse mammary gland.
    Biswas R; Vonderhaar BK
    Endocrinology; 1991 Jan; 128(1):532-8. PubMed ID: 1846110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin mediation of estrogen-induced changes in mammary tissue estrogen and progesterone receptors.
    Muldoon TG
    Endocrinology; 1987 Jul; 121(1):141-9. PubMed ID: 3595517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of steroidal and nonsteroidal antiestrogens on the growth of a tamoxifen-stimulated human endometrial carcinoma (EnCa101) in athymic mice.
    Gottardis MM; Ricchio ME; Satyaswaroop PG; Jordan VC
    Cancer Res; 1990 Jun; 50(11):3189-92. PubMed ID: 2334915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in mammary gland development following neonatal exposure to estradiol, transforming growth factor alpha, and estrogen receptor antagonist ICI 182,780.
    Hilakivi-Clarke L; Cho E; Raygada M; Kenney N
    J Cell Physiol; 1997 Mar; 170(3):279-89. PubMed ID: 9066785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profile of estrogen-responsive genes in an estrogen-specific mammary gland outgrowth model.
    Deroo BJ; Hewitt SC; Collins JB; Grissom SF; Hamilton KJ; Korach KS
    Mol Reprod Dev; 2009 Aug; 76(8):733-50. PubMed ID: 19484750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mouse model to study the effects of hormone replacement therapy on normal mammary gland during menopause: enhanced proliferative response to estrogen in late postmenopausal mice.
    Raafat AM; Hofseth LJ; Li S; Bennett JM; Haslam SZ
    Endocrinology; 1999 Jun; 140(6):2570-80. PubMed ID: 10342844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cadmium mimics the in vivo effects of estrogen in the uterus and mammary gland.
    Johnson MD; Kenney N; Stoica A; Hilakivi-Clarke L; Singh B; Chepko G; Clarke R; Sholler PF; Lirio AA; Foss C; Reiter R; Trock B; Paik S; Martin MB
    Nat Med; 2003 Aug; 9(8):1081-4. PubMed ID: 12858169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferative effects of combination estrogen and progesterone replacement therapy on the normal postmenopausal mammary gland in a murine model.
    Raafat AM; Hofseth LJ; Haslam SZ
    Am J Obstet Gynecol; 2001 Feb; 184(3):340-9. PubMed ID: 11228484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
    Lykkesfeldt AE; Madsen MW; Briand P
    Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo inhibition of keratinocyte growth factor receptor expression by estrogen and antagonism by progesterone in the mouse mammary gland.
    Imagawa W; Pedchenko VK
    J Endocrinol; 2001 Nov; 171(2):319-27. PubMed ID: 11691652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of estrogen and antiestrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells.
    Gong Y; Ballejo G; Murphy LC; Murphy LJ
    Cancer Res; 1992 Apr; 52(7):1704-9. PubMed ID: 1551100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of exogenous epidermal-like growth factors on mammary gland development and differentiation in the estrogen receptor-alpha knockout (ERKO) mouse.
    Kenney NJ; Bowman A; Korach KS; Barrett JC; Salomon DS
    Breast Cancer Res Treat; 2003 May; 79(2):161-73. PubMed ID: 12825851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progesterone action in normal mouse mammary gland.
    Wang S; Counterman LJ; Haslam SZ
    Endocrinology; 1990 Nov; 127(5):2183-9. PubMed ID: 2226309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.